Join the 200th Anniversary Celebration

Correction

A Comparison of Budesonide and Mesalamine for Active Crohn's Disease

N Engl J Med 2001; 345:1652November 29, 2001

Article

A Comparison of Budesonide and Mesalamine for Active Crohn's Disease (Original Article, N Engl J Med 1998:339;370 - 374) . On page 372, the sentence that begins on line 8 of the right-hand column should have read, “The median time to remission was also shorter in the budesonide group than in the mesalamine group (28 vs. 58 days, P=0.12),” not “(28 vs. 84 days, P =0.04).” as printed.

Citing Articles (1)

Citing Articles

  1. 1

    Wee-Chian Lim, Stephen Hanauer, Wee-Chian Lim. 2010. Aminosalicylates for induction of remission or response in Crohn's disease. .
    CrossRef